{
    "nctId": "NCT00590109",
    "briefTitle": "Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer",
    "officialTitle": "Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 383,
    "primaryOutcomeMeasure": "to further characterize inherited predisposition to breast cancer mediated by specific BRCA alleles among Jewish women.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients are eligible for the study if they are over 18 years of age, identify their ancestry as Jewish (both Sephardic and Ashkenazi Jews are eligible), have or have had a diagnosis of breast cancer, and are able to give informed consent.\n* Relatives, age 18 or older, of the patients who meet eligibility criteria above and are found to have a specific BRCA1 or BRCA2 mutation if they are able to give informed consent.",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}